Pedro OliveiraFounder & Project Leader, Patient Innovation
Founder & Project Leader
Pedro Oliveira is Associate Professor at the Católica-Lisbon School of Business and Economics; Academic Fellow at Cornell University’s Cornell Institute for Healthy Futures; Founder and Project Leader of Patient Innovation; and co-founder of PPL Crowdfunding Portugal. He is also the director of several executive education programs, including the Advanced Program in Entrepreneurship and Innovation Management (PAEGI) and the Supply Chain Management Program.
Previously he was Senior Associate Dean for Faculty and Research; Academic Director of the LisbonMBA (a joint-venture between Católica-Lisbon, NovaSBE, with the collaboration of MIT-Sloan); Director of the doctoral program in Technology Change and Entrepreneurship (jointly offered by Católica-Lisbon, IST and Carnegie Mellon University). He was also an International Faculty Fellow (IFF) at MIT Sloan School of Management and advisor to the Ministry of Science, Technology and Higher Education.
Pedro is Principal Investigator (PI) of several research grants funded by the Portuguese Science and Technology Foundation (FCT), the Peter Pribilla Foundation (Germany), the Norwegian Research Council (Norway) and the European Commission. He has served as Project Leader of Creative Commons Portugal.
His research has been published in Production and Operations Management (POM), Research Policy, Organizational Research Methods, Journal of Product Innovation Management (JPIM), International Journal of Operations and Production Management, Orphanet, New England Journal of Medicine – Catalyst, Technological Forecasting and Social Change among other.
He received his Ph.D. in Operations, Technology and Innovation Management from the University of North Carolina at Chapel Hill; and his M.Sc. and his “licenciatura” in Naval Engineering from Instituto Superior Técnico (IST). He also completed some advanced training at Harvard Business School and at Northwestern University’s Kellogg School of Management.
Subscribe To Our Newsletter
Join our mailing list to receive the latest news and updates from our team.